Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -1.93% is 663% below its 5-year average of 0.34%, near the low end of its 5-year range (-4.08%–15.35%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.26% below its 12-month average of -1.55%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -1.93%.
RETURN ON EQUITY (ROE)
-1.93%
RETURN ON EQUITY (ROE) AVG TTM
-1.55%
RETURN ON EQUITY (ROE) AVG 3Y
-0.69%
RETURN ON EQUITY (ROE) AVG 5Y
0.34%
RETURN ON EQUITY (ROE) AVG 10Y
5.61%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-24.26%
CURRENT VS 3Y AVG
-177.45%
CURRENT VS 5Y AVG
-662.74%
CURRENT VS 10Y AVG
-134.34%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
+95.41%
vs the sector median at left
RadNet, Inc.
Market Cap
$5.53B
Return on Equity (ROE)
-1.93%
TTM Avg
-1.55%
3Y Avg
-0.69%
5Y Avg
0.34%
Market Cap
$5.52B
Return on Equity (ROE)
-9.09%
TTM Avg
-8.34%
3Y Avg
-4.98%
5Y Avg
-4.98%
Market Cap
$5.61B
Return on Equity (ROE)
-21.80%
TTM Avg
-16.70%
3Y Avg
-22.00%
5Y Avg
-23.98%
Market Cap
$5.32B
Return on Equity (ROE)
N/A
TTM Avg
-149.71%
3Y Avg
-15.45%
5Y Avg
-6097.55%
Market Cap
$5.78B
Return on Equity (ROE)
-396.09%
TTM Avg
-131.69%
3Y Avg
-109.48%
5Y Avg
-82.27%
Market Cap
$5.79B
Return on Equity (ROE)
-39.33%
TTM Avg
-54.18%
3Y Avg
-65.89%
5Y Avg
-59.69%
Market Cap
$5.21B
Return on Equity (ROE)
-25.83%
TTM Avg
-24.61%
3Y Avg
-23.01%
5Y Avg
-16.21%
Market Cap
$5.21B
Return on Equity (ROE)
-177.24%
TTM Avg
-283.26%
3Y Avg
-317.97%
5Y Avg
-235.28%
Market Cap
$5.20B
Return on Equity (ROE)
24.56%
TTM Avg
11.91%
3Y Avg
-7.82%
5Y Avg
-3.31%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RadNet, Inc. (RDNT) | $5.53B | -1.93% | -1.55% | -0.69% | 0.34% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | -9.09% | -8.34% | -4.98% | -4.98% |
| CG Oncology Inc. (CGON)vs › | $5.61B | -21.80% | -16.70% | -22.00% | -23.98% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | N/A | -149.71% | -15.45% | -6097.55% |
| Kodiak Sciences Inc. (KOD)vs › | $5.78B | -396.09% | -131.69% | -109.48% | -82.27% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | -39.33% | -54.18% | -65.89% | -59.69% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | -25.83% | -24.61% | -23.01% | -16.21% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | -177.24% | -283.26% | -317.97% | -235.28% |
| Sotera Health Company (SHC)vs › | $5.20B | 24.56% | 11.91% | -7.82% | -3.31% |
| Doximity, Inc. (DOCS)vs › | $5.20B | 18.24% | 20.62% | 17.32% | 27.02% |
ROE
-1.9%
ROA
-0.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -1.93% |
| 2026-03-31 | -1.31% |
| 2025-12-31 | -1.71% |
| 2025-09-30 | -1.20% |
| 2025-06-30 | -1.60% |
| 2025-03-31 | -3.60% |
| 2024-12-31 | 0.31% |
| 2024-09-30 | -0.49% |
| 2024-06-30 | 1.13% |
| 2024-03-31 | 2.44% |
| 2023-12-31 | 0.48% |
| 2023-09-30 | 0.64% |
| 2023-06-30 | -2.18% |
| 2023-03-31 | -4.08% |
| 2022-12-31 | 3.20% |
| 2022-09-30 | 2.48% |
| 2022-06-30 | 7.47% |
| 2022-03-31 | 6.12% |
| 2021-12-31 | 10.80% |
| 2021-09-30 | 15.35% |
| 2021-06-30 | 12.40% |
| 2021-03-31 | 5.95% |
| 2020-12-31 | -8.95% |
| 2020-09-30 | -6.62% |
| 2020-06-30 | -9.04% |
| 2020-03-31 | 1.73% |
| 2019-12-31 | 9.73% |
| 2019-09-30 | 24.87% |
| 2019-06-30 | 26.39% |
| 2019-03-31 | 26.38% |
| 2018-12-31 | 25.35% |
| 2018-09-30 | -4.42% |
| 2018-06-30 | -6.85% |
| 2018-03-31 | -7.63% |
| 2017-12-31 | 0.08% |
| 2017-09-30 | 16.71% |
| 2017-06-30 | 16.56% |
| 2017-03-31 | 15.59% |
| 2016-12-31 | 14.91% |
| 2016-09-30 | 12.07% |
| 2016-06-30 | 32.45% |
| 2016-03-31 | 31.45% |
| 2015-12-31 | 23.66% |
| 2015-09-30 | 48.57% |
| 2015-06-30 | 73.39% |
| 2015-03-31 | 201.31% |
| 2014-12-31 | 25.66% |
| 2014-09-30 | -277.27% |
